Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01775072 · ClinicalTrials.gov registry record
Genomic Profiling in Cancer Patients
A clinical trial of Solid Tumors and Hematologic Cancers, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 200
- Enrollment target
- 18
- Study locations
NCT01775072 is a study of Solid Tumors and Hematologic Cancers that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 200 participants, below the 283-participant average among 125 other Solid Tumors trials with a reported enrollment target (29% lower). The trial reports 18 study locations across 5 states.
The verdict
NCT01775072, a study of Solid Tumors and Hematologic Cancers, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 18
- Study locations
Study Summary
The purpose of this study is to determine whether certain genes in cancer may be abnormal. When a gene is abnormal this is called a mutation. Most mutations in cancer cells are not inherited (passed down from parents) but happen after birth in the cancer itself. Most cancers have many mutations. Some of these mutations are important for the cancer cells to survive while others are not. The goal of this study is test cancer for certain mutations using leftover tumor tissue from a previous surgery or biopsy. Participants will also be asked to provide a tube of blood cheek (also known as a buccal) swab, or a saliva sample that contains normal genes for comparison. The purpose of Part B of this study is to: Understand how genetic changes in tumor effect the chance of responding to experimental cancer treatment. Understand how the genes in the tumor change overtime in response to targeted cancer treatment.
Conditions Studied
Interventions
- GENETIC molecular profiling of tumors
- GENETIC Clinical Germline Analysis
Study Locations (18)
New York
- Kings County Hopsital Center - Brooklyn
- Memorial Sloan Kettering Cancer Commack - Commack
- Memorial Sloan Kettering Westchester - Harrison
- Queens Cancer Center of Queens Hospital - Jamaica
- Metropolitan Hospital Center - New York
- Ralph Lauren Center for Cancer Care and Prevention - New York
- Memorial Sloan Kettering Cancer Center - New York
- Medisys Health Network (Data Collection Only) - Richmond Hill
- NYC Health & Hospitals /Lincoln Medical Center - The Bronx
- Memorial Sloan Kettering Nassau - Uniondale
Connecticut
- St. Vincent (Data Collection Only) - Bridgeport
- Hartford Healthcare Cancer Institute @ Hartford Hospital - Hartford
- Norwalk Hospital - Norwalk
New Jersey
- Memorial Sloan Kettering Basking Ridge - Basking Ridge
- Memorial Sloan Kettering Monmouth - Middletown
- Memorial Sloan Kettering Bergen - Montvale
Florida
- Baptist Alliance MCI - Miami
Pennsylvania
- Lehigh Valley Health Network - Allentown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2013-01 |
| Est. Completion | 2027-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01775072
The ClinicalTrials.gov registry entry for NCT01775072 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 283-participant average among 125 other Solid Tumors trials with a reported enrollment target (29% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Solid Tumors appearing as the primary indexed condition, and to 2 interventions - of which molecular profiling of tumors is the first listed.
NCT01775072 reports 18 study locations spanning 5 distinct geographic areas - top geographies include New York, Connecticut, New Jersey.
Frequently Asked Questions
What is clinical trial NCT01775072 about?
NCT01775072 is a clinical study titled "Genomic Profiling in Cancer Patients". The purpose of this study is to determine whether certain genes in cancer may be abnormal. When a gene is abnormal this is called a mutation. Most mutations in cancer cells are not inherited (passed down from parents) but happen after birth in the cancer itself. Most cancers have many mutations. Som...
What is the current status of trial NCT01775072?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2013-01. Estimated completion is 2027-01.
What conditions does trial NCT01775072 study?
This clinical trial studies the following conditions: Solid Tumors, Hematologic Cancers.
What interventions are being tested in trial NCT01775072?
The interventions under investigation include: molecular profiling of tumors (GENETIC), Clinical Germline Analysis (GENETIC).
Who is sponsoring clinical trial NCT01775072?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01775072 being conducted?
This trial has 18 study locations across Connecticut, Florida, New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
RECRUITING · Phase 4
-
A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of INCB123667 in Subjects With Advanced Solid Tumors
RECRUITING · Phase 1
-
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.